Diagnostic testing in neurogenetics. Principles, limitations, and ethical considerations

Neurol Clin. 2002 Aug;20(3):627-43, v. doi: 10.1016/s0733-8619(02)00009-9.

Abstract

Genetics has emphatically entered the practice of neurology. The last decade witnessed the discovery of the genetic basis of many diseases that primarily affect the nervous system. In areas such as neuromuscular and movement disorders, genetic testing has become a routine part of diagnostic testing. In areas like epilepsy, genetic advances likely will lead to new testing for certain patients. In dementia, the existence of a common predisposing genetic factor (apolipoprotein E) has already raised complex issues such as the appropriateness of genetic testing in specific clinical situations--issues that neurologists will confront more in the future. This article reviews basic principles of genetic testing, its application to neurology, and some limitations and ethical issues confronting the field.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / genetics
  • Apolipoproteins E / genetics
  • Central Nervous System Diseases / diagnosis
  • Central Nervous System Diseases / genetics*
  • Ethics, Medical*
  • Genetic Markers / genetics
  • Genetic Testing / ethics*
  • Genotype
  • Humans
  • Molecular Diagnostic Techniques / ethics*
  • Movement Disorders / diagnosis
  • Movement Disorders / genetics*
  • Neuromuscular Diseases / diagnosis
  • Neuromuscular Diseases / genetics*
  • Predictive Value of Tests

Substances

  • Apolipoproteins E
  • Genetic Markers